期刊文献+

Arg早期强化的EN对胃癌患者术后免疫功能的影响 被引量:4

Influence of Arg early enhanced EN on postoperative immune function of gastric cancer patients
下载PDF
导出
摘要 目的分析联合应用精氨酸(Arg)肠内营养(EN)对胃癌患者根治术后免疫功能的影响,以评价免疫营养对于胃癌患者的化疗疗效、不良反应、生活质量、无进展生存期(PFS)的影响。方法收集符合纳入标准(经PG-SGA评分筛选)的胃癌患者90例,随机分成三组:单纯化疗组(A组)、Arg联合化疗组(B组),术后Arg联合化疗组(C组),每组30例。检测免疫指标、不良反应及无进展生存期指标等。结果经营养治疗后,A、B、C三组的免疫营养状态均呈逐渐好转趋势,但免疫指标B、C组均明显高于A组(P<0.05),B、C组中位无进展生存期高于A组(P<0.05)。结论早期给予精氨酸强化的肠内营养,可增强胃癌患者机体免疫功能,以提高临床化疗效果,明显改善患者生存质量。 Objective To analyze the influence of joint application of arginine (Arg) and enteral nutrition (EN) on the immune function of gastric cancer patients after radical surgery, in order to evaluate the influence of immune nutrition on chemotherapy effects, adverse reactions, quality of life, and progression-free survival (PFS) of gastric cancer patients.Methods A total of 90 gastric cancer patients, who met the enrolling standard (screening by PG-SGA score), were randomly divided into three group as single chemotherapy group (group A), Arg combined with chemotherapy group (group B) and postoperative Arg combined with chemotherapy group (group C), and each group contained 30 cases. Detection was made on immune index, adverse reaction and PFS indicators. Results After the nutrition treatment, the immune nutritional status were all improved in the three groups, while the immune index in groups B and C were higher than group A (P〈0.05). PFS was also higher in groups B and C than group A (P〈0.05).Conclusion Early application of Arg enhanced EN can improve immune function in patients with gastric cancer, and it can also improve clinical effect of chemotherapy and patients’ life quality.
出处 《中国实用医药》 2015年第3期1-3,共3页 China Practical Medicine
基金 国家自然科学基金(项目编号:81071808) 安徽省科技攻关项目(项目编号:12010402126)
关键词 精氨酸 胃癌 早期 肠内营养 Arginine Gastric cancer Early Enteral nutritionw
  • 相关文献

参考文献5

二级参考文献23

  • 1Guo Hao Wu Yan Wei Zhang Zhao Han Wu Department of General Surgery.zhongshan Hospital,ShangHai Medical University.ShangHai 200032.China.Modulation of postoperative immune and inflammatory response by immune-enhancing enteral diet in gastrointestinal cancer patients[J].World Journal of Gastroenterology,2001,7(3):357-362. 被引量:67
  • 2吴国豪,ConnieJarstrand,JorgenNordenstrom.吞噬细胞介导的不同脂肪乳剂的脂质过氧化以及维生素E的抗氧化作用[J].中国临床营养杂志,1999,7(2):66-69. 被引量:14
  • 3[1]Milner JA, Stepanovich LV. Inhibitory effect of dietary arginine on growth of Ehrlich ascites tumor cells in mice. J Nutr ,1979 , 109(3):489~494. 被引量:1
  • 4[2]Sheng-long Ye, MD, MS, et al. Tumor and host response to arginine and branched chain amino acid-enriched total parenteral nutrition. Cancer ,1992,69:261~270. 被引量:1
  • 5[3]Edwards PD, Topping D, Kontaridis MI,et al. Arginine-enhanced enteral nutrition augments the growth of a nitric oxide-producing tumor. JPEN J Parenter Enteral Nutr, 1997,21(4):215~219. 被引量:1
  • 6[4]Park KGM, Heys SD, Blessing K, et al. Stimulation of human breast cancers by dietartary L-arginine.Clin Sci,1992, 82: 413. 被引量:1
  • 7[5]Terrault NA, Zhou S, McCory RW, et al. Incidence and clinical consequences of surface and polymerase gene mutations in liver transplant recipients on hepatitis B immunoglobulin. Hepatology, 1998, 28(2): 555. 被引量:1
  • 8[6]Grossie VB Jr,Nishioka K. Effect of ornithine in parenteral nutrition regimens on difluoromethy-lornithine-induced platelet suppression and changes in tumor polyamine content. Cancer Invest,1998,16(3): 160. 被引量:1
  • 9[7]Grossie VB Jr, Nishioka K, Ajani JA, et al. Substituting ornithine for arginine in total parenteral nutrition eliminates enhanced tumor growth. J Surg Oncol 1992,50(3):161. 被引量:1
  • 10Daly JM, Reynolds J, Thom A, et al. Immune and metabolic effects of arginine in the surgical patient. Ann Surg, 1988,208:512-523. 被引量:1

共引文献99

同被引文献67

引证文献4

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部